These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 6260604)
21. Interrelation at plasmatic level between antiepileptic drugs and lipids. Its implications in the efficiency of treatment in epilepsy. III. Changes induced by phenobarbital or/and diphenylhydantoin in serum lipids, lipoproteins and cortisol. Rogozea R; Florea-Ciocoiu V; Bălăiţă C; Luca N Neurol Psychiatr (Bucur); 1982; 20(2):89-100. PubMed ID: 7123121 [No Abstract] [Full Text] [Related]
22. [Acute polyneuropathy caused by diphenylhydantoin intoxication (author's transl)]. Meienberg O; Bajc O Dtsch Med Wochenschr; 1975 Jul; 100(29):1532-4, 1539. PubMed ID: 168051 [TBL] [Abstract][Full Text] [Related]
23. Adverse effects of phenytoin on peripheral nerves and neuromuscular junction: a review. So EL; Penry JK Epilepsia; 1981 Aug; 22(4):467-73. PubMed ID: 6266823 [TBL] [Abstract][Full Text] [Related]
24. Diphenylhydantoin-induced gingival hyperplasia: its response to changes in drug dosage. Little TM; Girgis SS; Masotti RE Dev Med Child Neurol; 1975 Aug; 17(4):421-4. PubMed ID: 1158048 [TBL] [Abstract][Full Text] [Related]
25. [Diphenylhydantoin poisoning in monotherapy and in combination with other antiepileptic drugs]. Schelp AO; Weisner B Arq Neuropsiquiatr; 1985 Jun; 43(2):176-80. PubMed ID: 4062602 [TBL] [Abstract][Full Text] [Related]
26. Phenytoin neuropathy: structural changes in the sural nerve. Ramirez JA; Mendell JR; Warmolts JR; Griggs RC Ann Neurol; 1986 Feb; 19(2):162-7. PubMed ID: 3008637 [TBL] [Abstract][Full Text] [Related]
27. Presenile cataracts in hydantoin-treated epileptic patients. Savir H; Bar S; Feller N Metab Pediatr Syst Ophthalmol; 1983; 7(3):169-71. PubMed ID: 6656625 [TBL] [Abstract][Full Text] [Related]
28. Lacking the 'protective label' of diabetes: Phenytoin-induced distal symmetrical peripheral neuropathy. A clinical case report. Mahon AM J Tissue Viability; 2016 Nov; 25(4):225-228. PubMed ID: 27372177 [TBL] [Abstract][Full Text] [Related]
29. Quantitative vibration perception thresholds in patients under prolonged antiepileptic treatment. Halonen P; Lang HA; Nyrke T Acta Neurol Scand; 1985 Sep; 72(3):307-11. PubMed ID: 2998143 [TBL] [Abstract][Full Text] [Related]
30. Treatment of diabetic neuropathy with diphenylhydantoin. Ellenberg M N Y State J Med; 1968 Oct; 68(20):2653-5. PubMed ID: 4300475 [No Abstract] [Full Text] [Related]
31. Late peripheral neuropathy due to an acute voluntary intoxication by organophosphorus compounds. Curtes JP; Develay P; Hubert JP Clin Toxicol; 1981 Dec; 18(12):1453-62. PubMed ID: 6277553 [No Abstract] [Full Text] [Related]
32. Chromosomal damage in epileptics on monotherapy with carbamazepine and diphenylhydantoin. Herha J; Obe G Hum Genet; 1976 Dec; 34(3):255-63. PubMed ID: 1002148 [TBL] [Abstract][Full Text] [Related]
33. Phenytoin: effective but insidious therapy for epilepsy in people with intellectual disability. Iivanainen M J Intellect Disabil Res; 1998 Dec; 42 Suppl 1():24-31. PubMed ID: 10030428 [TBL] [Abstract][Full Text] [Related]
34. [Plasma levels of diphenylhydantoin (DPH) and phenobarbitone (PB) in epileptic patients resistant to drug treatment (author's transl)]. Zaccara G; Galli A; Rossi L; Zappoli R; Zatelli L; Amaducci L Riv Patol Nerv Ment; 1977; 98(6):363-75. PubMed ID: 754251 [TBL] [Abstract][Full Text] [Related]